C. elegans screening strategies to identify pro-longevity interventions

Mechanisms of Ageing and Development

Volumn 157, Issue , 2016, Pages 60-69

  Maglioni, Silvia ^b   Arsalan, Nayna ^b   Ventura, Natascia ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

Author keywords

Aging; C. elegans; Development; In vivo drug screening; Mitochondria

Indexed keywords

AGING; CAENORHABDITIS ELEGANS; CELLULAR STRESS RESPONSE; DRUG SCREENING; DRUG TARGETING; LONGEVITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; METABOLISM; MITOCHONDRION; MUTATION; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CAENORHABDITIS ELEGANS; LONGEVITY; MITOCHONDRIA; MUTATION; STRESS, PHYSIOLOGICAL;

EID: 84982814955     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.07.010     Document Type: Review

References (129)

1. Alberts, B., Johnson, A., Lewis, J., et al. Molecular biology of the cell. The Mouse, 4th edition, 2002, Garland Science, New York.
2. Altun, Z.F., Herndon, L.A., Wolkow, C.A., Crocker, C., Lints, R., Hall, D.H., WormAtlas. 2002–2015 14.10.2015. 2016 (Available from:) http://www.wormatlas.org.
3. Antoshechkin, I., Sternberg, P.W., The versatile worm: genetic and genomic resources for Caenorhabditis elegans research. Nat. Rev. Genet. 8:7 (2007), 518–532.
4. Artal-Sanz, M., de Jong, L., Tavernarakis, N., Caenorhabditis elegans: a versatile platform for drug discovery. Biotechnol. J. 1:12 (2006), 1405–1418.
5. Avila, D., Helmcke, K., Aschner, M., The Caenorhabiditis elegans model as a reliable tool in neurotoxicology. Hum. Exp. Toxicol. 31:3 (2012), 236–243.
6. Azzu, V., Brand, M.D., The on-off switches of the mitochondrial uncoupling proteins. Trends Biochem. Sci. 35:5 (2010), 298–307.
7. Boyd, W.A., et al. Medium- and high-throughput screening of neurotoxicants using C. elegans. Neurotoxicol. Teratol. 32:1 (2010), 68–73.
8. Boyd, W.A., Smith, M.V., Freedman, J.H., Caenorhabditis elegans as a model in developmental toxicology. Methods Mol. Biol. 889 (2012), 15–24.
9. Brandish, P.E., et al. A cell-based ultra-high-throughput screening assay for identifying inhibitors of D-amino acid oxidase. J. Biomol. Screen 11:5 (2006), 481–487.
10. Bratic, A., Larsson, N.G., The role of mitochondria in aging. J. Clin. Investig. 123:3 (2013), 951–957.
11. Braungart, E., et al. Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings. Neurodegener. Dis. 1:4–5 (2004), 175–183.
12. Breger, J., et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog., 3(2), 2007, e18.
13. Brenner, S., The genetics of Caenorhabditis elegans. Genetics 77:1 (1974), 71–94.
14. Buchser, W., et al. Assay development guidelines for image-based high content screening, high content analysis and high content imaging. Sittampalam, G.S., (eds.) Assay Guidance Manual, 2004, Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda (MD).
15. Butler, J.A., et al. A metabolic signature for long life in the Caenorhabditis elegans Mit mutants. Aging Cell 12:1 (2013), 130–138.
16. Calabrese, E.J., Hormesis: a revolution in toxicology, risk assessment and medicine. EMBO Rep. 5 (2004), S37–S40 (Sec No).
17. Campisi, J., Aging, tumor suppression and cancer: high wire-act!. Mech. Ageing Dev. 126:1 (2005), 51–58.
18. Cardoso, A.R., Queliconi, B.B., Kowaltowski, A.J., Mitochondrial ion transport pathways: role in metabolic diseases. Biochim. Biophys. Acta 1797:6-7 (2010), 832–838.
19. Chen, D., et al. Longevity determined by developmental arrest genes in Caenorhabditis elegans. Aging Cell 6:4 (2007), 525–533.
20. Chin, R.M., et al. The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 510:7505 (2014), 397–401.
21. Curran, S.P., Ruvkun, G., Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet., 3(4), 2007, e56.
22. Dancy, B.M., Sedensky, M.M., Morgan, P.G., Effects of the mitochondrial respiratory chain on longevity in C. elegans. Exp. Gerontol. 56 (2014), 245–255.
23. Dell'agnello, C., et al. Increased longevity and refractoriness to Ca(2+)-dependent neurodegeneration in Surf1 knockout mice. Hum. Mol. Genet. 16:4 (2007), 431–444.
24. Dillin, A., et al. Rates of behavior and aging specified by mitochondrial function during development. Science 298:5602 (2002), 2398–2401.
25. Durieux, J., Wolff, S., Dillin, A., The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144:1 (2011), 79–91.
26. Evason, K., et al. Anticonvulsant medications extend worm life-span. Science 307:5707 (2005), 258–262.
27. Faber, P.W., et al. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl. Acad. Sci. U. S. A. 96:1 (1999), 179–184.
28. Feng, J., Bussiere, F., Hekimi, S., Mitochondrial electron transport is a key determinant of life span in Caenorhabditis elegans. Dev. Cell 1:5 (2001), 633–644.
29. Fraser, A.G., et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408:6810 (2000), 325–330.
30. Gaud, A., et al. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans. Neuromuscul. Disord. 14:6 (2004), 365–370.
31. Giacomotto, J., Segalat, L., High-throughput screening and small animal models, where are we?. Br. J. Pharmacol. 160:2 (2010), 204–216.
32. Giacomotto, J., et al. Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy. Hum. Mol. Genet. 18:21 (2009), 4089–4101.
33. Giacomotto, J., et al. Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods. Methods 56:1 (2012), 103–113.
34. Gill, M.S., et al. An automated high-throughput assay for survival of the nematode Caenorhabditis elegans. Free Radic. Biol. Med. 35:6 (2003), 558–565.
35. Gosai, S.J., et al. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin alpha1-antitrypsin Z. PLoS One, 5(11), 2010, e15460.
36. Gruber, J., et al. Caenorhabditis elegans: what we can and cannot learn from aging worms. Antioxid. Redox Signal. 23:3 (2015), 256–279.
37. Hamilton, B., et al. A systematic RNAi screen for longevity genes in C. elegans. Genes Dev. 19:13 (2005), 1544–1555.
38. Hansen, M., et al. New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen. PLoS Genet. 1:1 (2005), 119–128.
39. Hansen, M., et al. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 6:1 (2007), 95–110.
40. Houtkooper, R.H., et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 497:7450 (2013), 451–457.
41. Johannsen, D.L., Ravussin, E., The role of mitochondria in health and disease. Curr. Opin. Pharmacol. 9:6 (2009), 780–786.
42. Jung, S.K., et al. Multi-endpoint: high-throughput study of nanomaterial toxicity in Caenorhabditis elegans. Environ. Sci. Technol. 49:4 (2015), 2477–2485.
43. Kahn, N.W., et al. Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans. Biochem. J. 409:1 (2008), 205–213.
44. Kaletta, T., Hengartner, M.O., Finding function in novel targets: C. elegans as a model organism. Nature, 2006.
45. Kaletta, T., Hengartner, M.O., Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5:5 (2006), 387–398.
46. Kapahi, P., Protein synthesis and the antagonistic pleiotropy hypothesis of aging. Adv. Exp. Med. Biol. 694 (2010), 30–37.
47. Khan, M.H., et al. TAF-4 is required for the life extension of isp-1, clk-1 and tpk-1 Mit mutants. Aging (Albany NY) 5:10 (2013), 741–758.
48. Kim, Y., Sun, H., Functional genomic approach to identify novel genes involved in the regulation of oxidative stress resistance and animal lifespan. Aging Cell 6:4 (2007), 489–503.
49. Kraemer, B.C., et al. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. U. S. A. 100:17 (2003), 9980–9985.
50. Kwok, T.C., et al. A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441:7089 (2006), 91–95.
51. Lakso, M., et al. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J. Neurochem. 86:1 (2003), 165–172.
52. Lee, S.S., et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat. Genet. 33:1 (2003), 40–48.
53. Lee, M.Y., et al. Three-dimensional cellular microarray for high-throughput toxicology assays. Proc. Natl. Acad. Sci. U. S. A. 105:1 (2008), 59–63.
54. Lee, S.J., Hwang, A.B., Kenyon, C., Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr. Biol. 20:23 (2010), 2131–2136.
55. Leung, M.C., et al. Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol. Sci. 106:1 (2008), 5–28.
56. Leung, C.K., et al. High-throughput screening and biosensing with fluorescent C. elegans strains. J. Vis. Exp., 51, 2011.
57. Leung, C.K., et al. An ultra high-throughput, whole-animal screen for small molecule modulators of a specific genetic pathway in Caenorhabditis elegans. PLoS One, 8(4), 2013, e62166.
58. Levitan, D., et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 93:25 (1996), 14940–14944.
59. Link, C.D., Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 92:20 (1995), 9368–9372.
60. Lithgow, G.J., et al. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc. Natl. Acad. Sci. U. S. A. 92:16 (1995), 7540–7544.
61. Liu, B., Li, S., Hu, J., Technological advances in high-throughput screening. Am. J. Pharmacogenom. 4:4 (2004), 263–276.
62. Liu, X., et al. Evolutionary conservation of the clk-1-dependent mechanism of longevity: loss of mclk1 increases cellular fitness and lifespan in mice. Genes Dev. 19:20 (2005), 2424–2434.
63. Liu, Y., et al. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 508:7496 (2014), 406–410.
64. Lucanic, M., Lithgow, G.J., Alavez, S., Pharmacological lifespan extension of invertebrates. Ageing Res. Rev. 12:1 (2013), 445–458.
65. Lucanic, M., et al. Chemical activation of a food deprivation signal extends lifespan. Aging Cell, 2016.
66. Maglioni, S., Ventura, N., C. elegans as a model organism for human mitochondrial associated disorders. Mitochondrion, 2016.
67. Maglioni, S., et al. Mitochondrial stress extends lifespan in C. elegans through neuronal hormesis. Exp. Gerontol. 56 (2014), 89–98.
68. Maglioni, S., et al. An automated phenotype-based microscopy screen to identify pro-longevity interventions acting through mitochondria in C. elegans. Biochim. Biophys. Acta 1847:11 (2015), 1469–1478.
69. Mayr, L.M., Fuerst, P., The future of high-throughput screening. J. Biomol. Screen 13:6 (2008), 443–448.
70. McInnes, J., Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr. Metab. (Lond.), 10(1), 2013, 63.
71. Mishur, R.J., et al. Mitochondrial metabolites extend lifespan. Aging Cell 15:2 (2016), 336–348.
72. Moy, T.I., et al. Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. U. S. A. 103:27 (2006), 10414–10419.
73. Munkacsy, E., Rea, S.L., The paradox of mitochondrial dysfunction and extended longevity. Exp. Gerontol. 56 (2014), 221–233.
74. Murphy, M.P., et al. Unraveling the biological roles of reactive oxygen species. Cell Metab. 13:4 (2011), 361–366.
75. Nayak, S., et al. Development of small molecular proteasome inhibitors using a Caenorhabditis elegans screen. Int. J. Med. Chem., 2014, 2014, 237286.
76. Ni, Z., Lee, S.S., RNAi screens to identify components of gene networks that modulate aging in Caenorhabditis elegans. Brief Funct. Genom. 9:1 (2010), 53–64.
77. Ni, H.M., Williams, J.A., Ding, W.X., Mitochondrial dynamics and mitochondrial quality control. Redox Biol. 4 (2015), 6–13.
78. O'Reilly, L.P., et al. C. elegans in high-throughput drug discovery. Adv. Drug Deliv. Rev. 69–70 (2014), 247–253.
79. Oeda, T., et al. Oxidative stress causes abnormal accumulation of familial amyotrophic lateral sclerosis-related mutant SOD1 in transgenic Caenorhabditis elegans. Hum. Mol. Genet. 10:19 (2001), 2013–2023.
80. Park, S.K., Tedesco, P.M., Johnson, T.E., Oxidative stress and longevity in Caenorhabditis elegans as mediated by SKN-1. Aging Cell 8:3 (2009), 258–269.
81. Peterson, R.T., et al. Use of non-mammalian alternative models for neurotoxicological study. Neurotoxicology 29:3 (2008), 546–555.
82. Petrascheck, M., Ye, X., Buck, L.B., An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 450:7169 (2007), 553–556.
83. Petrascheck, M., Ye, X., Buck, L.B., A high-throughput screen for chemicals that increase the lifespan of Caenorhabditis elegans. Ann. N. Y. Acad. Sci. 1170 (2009), 698–701.
84. Promislow, D.E., Protein networks: pleiotropy and the evolution of senescence. Proc. Biol. Sci. 271:1545 (2004), 1225–1234.
85. Rauthan, M., Pilon, M., A chemical screen to identify inducers of the mitochondrial unfolded protein response in C. elegans. Worm, 4(4), 2015, e1096490.
86. Rea, S.L., Ventura, N., Johnson, T.E., Relationship between mitochondrial electron transport chain dysfunction, development, and life extension in Caenorhabditis elegans. PLoS Biol., 5(10), 2007, e259.
87. Rea, S.L., Metabolism in the Caenorhabditis elegans Mit mutants. Exp. Gerontol. 40:11 (2005), 841–849.
88. Riddle, C.elegans, vol. 2, 2016, cold sprig harbour, 1997.
89. Ristow, M., Schmeisser, K., Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response 12:2 (2014), 288–341.
90. Ristow, M., Zarse, K., How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 45:6 (2010), 410–418.
91. Schiavi, A., Ventura, N., The interplay between mitochondria and autophagy and its role in the aging process. Exp. Gerontol. 56 (2014), 147–153.
92. Schiavi, A., et al. Autophagy induction extends lifespan and reduces lipid content in response to frataxin silencing in C. elegans. Exp. Gerontol. 48:2 (2013), 191–201.
93. Schiavi, A., et al. Iron-starvation-induced mitophagy mediates lifespan extension upon mitochondrial stress in C. elegans. Curr. Biol. 25:14 (2015), 1810–1822.
94. Schmeisser, S., et al. Mitochondrial hormesis links low-dose arsenite exposure to lifespan extension. Aging Cell 12:3 (2013), 508–517.
95. Schmeisser, S., et al. Neuronal ROS signaling rather than AMPK/sirtuin-mediated energy sensing links dietary restriction to lifespan extension. Mol. Metab. 2:2 (2013), 92–102.
96. Segalat, L., Drug discovery: here comes the worm. ACS Chem. Biol. 1:5 (2006), 277–278.
97. Segalat, L., Loss-of-function genetic diseases and the concept of pharmaceutical targets. Orphanet. J. Rare Dis., 2, 2007, 30.
98. Segalat, L., Invertebrate animal models of diseases as screening tools in drug discovery. ACS Chem. Biol. 2:4 (2007), 231–236.
99. Silverman, G.A., et al. Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans. Pediatr. Res. 65:1 (2009), 10–18.
100. Simmer, F., et al. Genome-wide RNAi of C. elegans using the hypersensitive rrf-3 strain reveals novel gene functions. PLoS Biol., 1(1), 2003, E12.
101. Sinha, A., Rae, R., A functional genomic screen for evolutionarily conserved genes required for lifespan and immunity in germline-deficient C. elegans. PLoS One, 9(8), 2014, e101970.
102. Song, P., et al. A microfluidic device for efficient chemical testing using Caenorhabditis elegans. Biomed. Microdevices, 17(2), 2015, 38.
103. Spencer, S.L., Sorger, P.K., Measuring and modeling apoptosis in single cells. Cell 144:6 (2011), 926–939.
104. Sun, J., et al. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 161:2 (2002), 661–672.
105. Szymanski, P., Markowicz, M., Mikiciuk-Olasik, E., Adaptation of high-throughput screening in drug discovery-toxicological screening tests. Int. J. Mol. Sci. 13:1 (2012), 427–452.
106. Tapia, P.C., Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: “Mitohormesis” for health and vitality. Med. Hypotheses 66:4 (2006), 832–843 Epub 2005 Oct 18. PMID: 16242247.
107. Torgovnick, A., et al. A role for p53 in mitochondrial stress response control of longevity in C. elegans. Exp. Gerontol. 45:7–8 (2010), 550–557.
108. Torgovnick, A., et al. Healthy aging: what can we learn from Caenorhabditis elegans?. Z. Gerontol. Geriatr. 46:7 (2013), 623–628.
109. Tsang, W.Y., et al. Mitochondrial respiratory chain deficiency in Caenorhabditis elegans results in developmental arrest and increased life span. J. Biol. Chem. 276:34 (2001), 32240–32246.
110. Ungewitter, E., Scrable, H., Antagonistic pleiotropy and p53. Mech. Ageing Dev. 130:1–2 (2009), 10–17.
111. Vafai, S.B., Mootha, V.K., Mitochondrial disorders as windows into an ancient organelle. Nature 491:7424 (2012), 374–383.
112. Ventura, N., Rea, S.L., Caenorhabditis elegans mitochondrial mutants as an investigative tool to study human neurodegenerative diseases associated with mitochondrial dysfunction. Biotechnol. J. 2:5 (2007), 584–595.
113. Ventura, N., et al. Reduced expression of frataxin extends the lifespan of Caenorhabditis elegans. Aging Cell 4:2 (2005), 109–112.
114. Ventura, N., Rea, S.L., Testi, R., Long-lived C. elegans mitochondrial mutants as a model for human mitochondrial-associated diseases. Exp. Gerontol. 41:10 (2006), 974–991.
115. Ventura, N., et al. p53/CEP-1 increases or decreases lifespan: depending on level of mitochondrial bioenergetic stress. Aging Cell 8:4 (2009), 380–393.
116. Walter, L., et al. The homeobox protein CEH-23 mediates prolonged longevity in response to impaired mitochondrial electron transport chain in C. elegans. PLoS Biol., 9(6), 2011, e1001084.
117. West, D.B., et al. Mouse genetics/genomics: an effective approach for drug target discovery and validation. Med. Res. Rev. 20:3 (2000), 216–230.
118. Williams, G.C., Pleiotropy, natural selection, and the evolution of senescence. Evolution 11:4 (1957), 398–411.
119. Wong, A., Boutis, P., Hekimi, S., Mutations in the clk-1 gene of Caenorhabditis elegans affect developmental and behavioral timing. Genetics 139:3 (1995), 1247–1259.
120. Wood, The Nematode Caenorhabditis Elegans. 2016, cold spring harbour, 1988.
121. Xian, B., et al. WormFarm: a quantitative control and measurement device toward automated Caenorhabditis elegans aging analysis. Aging Cell, 2013.
122. Yang, W., Hekimi, S., A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol., 8(12), 2010, e1000556.
123. Ye, X., et al. A pharmacological network for lifespan extension in Caenorhabditis elegans. Aging Cell 13:2 (2014), 206–215.
124. Yin, F., Cadenas, E., Mitochondria: the cellular hub of the dynamic coordinated network. Antioxid. Redox Signal. 22:12 (2015), 961–964.
125. Yoneda, T., et al. Compartment-specific perturbation of protein handling activates genes encoding mitochondrial chaperones. J. Cell Sci. 117:Pt 18 (2004), 4055–4066.
126. Yun, J., Finkel, T., Mitohormesis. Cell Metab. 19:5 (2014), 757–766.
127. Zarse, K., et al. Impaired respiration is positively correlated with decreased life span in Caenorhabditis elegans models of Friedreich Ataxia. FASEB J. 21:4 (2007), 1271–1275.
128. Zhou, Y.M., et al. An efficient and novel screening model for assessing the bioactivity of extracts against multidrug-resistant Pseudomonas aeruginosa using Caenorhabditis elegans. Biosci. Biotechnol. Biochem. 75:9 (2011), 1746–1751.
129. Zhou, K.I., Pincus, Z., Slack, F.J., Longevity and stress in Caenorhabditis elegans. Aging (Albany NY) 3:8 (2011), 733–753.